Market capitalization | $433.50m |
Enterprise Value | $483.67m |
P/E (TTM) P/E ratio | 16.16 |
EV/FCF (TTM) EV/FCF | 21.31 |
EV/Sales (TTM) EV/Sales | 3.36 |
P/S ratio (TTM) P/S ratio | 3.01 |
P/B ratio (TTM) P/B ratio | 12.31 |
Dividend yield | 2.64% |
Last dividend (FY24) | $0.48 |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
2 Analysts have issued a National Research Corporation forecast:
2 Analysts have issued a National Research Corporation forecast:
Sep '24 |
+/-
%
|
||
Revenue | 144 144 |
3%
3%
|
|
Gross Profit | 82 82 |
6%
6%
|
|
EBITDA | 43 43 |
7%
7%
|
EBIT (Operating Income) EBIT | 37 37 |
8%
8%
|
Net Profit | 27 27 |
6%
6%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.
Head office | United States |
CEO | Michael Hays |
Employees | 435 |
Founded | 1981 |
Website | www.nrchealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.